Overview

Diabetic Macular Edema Treated With Ozurdex (DMEO)

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To measure various pro-permeability factors in the aqueous humor of patients with persistent/recurrent diabetic macular edema
Phase:
Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
BB 1101
Bevacizumab
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate